(Q45762363)

15 December 2017

title

Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients (English)

1 reference

15 December 2017

1 reference

peripheral neuropathy

1 reference

Chemotherapy-induced peripheral neuropathy

inferred from title

1 reference

Rebecca M Speck

1

1 reference

15 December 2017

Angela DeMichele

2

1 reference

15 December 2017

John T Farrar

3

1 reference

15 December 2017

Sean Hennessy

4

1 reference

15 December 2017

Jun J Mao

5

1 reference

15 December 2017

Margaret G Stineman

6

1 reference

15 December 2017

Frances K Barg

7

1 reference

15 December 2017

publication date

11 January 2012

1 reference

15 December 2017

Supportive Care in Cancer

published in

1 reference

15 December 2017

volume

20

1 reference

15 December 2017

issue

10

1 reference

15 December 2017

page(s)

2433-2439

1 reference

15 December 2017

Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

Chemotherapy dose reduction and delay in clinical practice. evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

The missing voice of patients in drug-safety reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

Pharmacogenomics of sex difference in chemotherapeutic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

Managing treatment side effects in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

Complementary and alternative medicine in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

Background noise: the experience of chemotherapy-induced peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

Patient perceptions associated with chemotherapy-induced peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

Clinical challenges: chemotherapy-induced peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

A questionnaire survey of physicians' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

Beginning with the application in mind: designing and planning health behavior change interventions to enhance dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-011-1365-8

Chemotherapy-induced peripheral neuropathy: A need for standardization in measurement

21 January 2018

1 reference

12 December 2020

Chemotherapy-induced peripheral neurotoxicity

1 reference

12 December 2020

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B

1 reference

12 December 2020

On the toxicity of chemotherapy for breast cancer--the need for vigilance

1 reference

12 December 2020

10.1007/S00520-011-1365-8

Identifiers

DOI

1 reference

15 December 2017

Dimensions Publication ID

1043551966

0 references

1 reference

15 December 2017